Aabo-Rosendal ApS: Financial statements 2022
CVR: 37086029
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Aabo-Rosendal ApS (CVR 37086029) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 4,159,005 and a net result of DKK 2,254,841 compared with DKK 1,766,281 the year before. That is an increase of 18.8% compared with the year before. Equity in the 2022 report amounted to DKK 2,342,555. The solvency ratio was 71.2%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 4,159,005
- Profit/Loss
- DKK 2,254,841
- Equity
- DKK 2,342,555
- Total Assets
- DKK 3,291,053
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 4.2 mio. | 2.3 mio. | 2.3 mio. | 4 |
| 2021 | - | 3.5 mio. | 1.8 mio. | 1.8 mio. | 2 |
| 2020 | - | 2.1 mio. | 567 t. | 641 t. | 2 |
| 2019 | - | 1.9 mio. | 499 t. | 575 t. | 3 |
| 2018 | - | 3.8 mio. | 1.8 mio. | 1.9 mio. | 2 |
Official annual report
Keep an eye on Aabo-Rosendal ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Aabo-Rosendal ApS has published its annual report for 2021. Gross profit came to DKK 3,500,413, and the net result was DKK 1,766,281.
About Aabo-Rosendal ApS
Aabo-Rosendal ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company has been dissolved on 13 June 2025. The company was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Neurokirurgisk Smerteklinik ApS. The company has 2 employees (2024). In 2023, the company reported a gross profit of DKK 2,784,347 and a net result of DKK 1,134,946 compared with DKK 2,254,841 the year before. Equity in the 2023 report amounted to DKK 1,227,501.